Biopolio 2ml Vaccines

Biopolio 2ml Vaccines is an inactivated polio vaccine (IPV) specifically formulated for the prevention of poliomyelitis, a severe viral infection capable of causing paralysis. This vaccine contains inactivated poliovirus Types 1 (Mahoney), 2 (MEF-1), and 3 (Saukett), which work by stimulating the immune system to produce protective IgG antibodies against the virus without inducing the disease itself.

Administered by injection, Biopolio 2ml Vaccines is integrated into national health initiatives such as the Universal Immunisation Programme. The recommended immunization schedule for this Fractional IPV (FIPV) includes three primary doses administered at 6, 10, and 14 weeks of age, followed by a booster dose between 15 and 18 months of age.

Manufactured by Bharat Biotech, Biopolio 2ml Vaccines is produced under the regulatory oversight of Indian authorities, ensuring its quality and suitability for clinical application.

Key Features : 

Antigen Composition: Inactivated Poliovirus Types 1, 2, and 3
Approved Indications and Target Population: Prevention of poliomyelitis in infants and children
Route of Administration: Injection (Intramuscular or Subcutaneous)
Schedule / Dosing Intervals: Primary series at 6, 10, 14 weeks of age; booster at 15-18 months (FIPV)
Regulatory Approval: Indian Regulatory Approval (CDSCO)